Monopar Therapeutics (MNPR) Enterprise Value (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.57% |
| Sep 30, 2025 | -223.22% |
| Jun 30, 2025 | 0.53% |
| Mar 31, 2025 | 13.32% |
| Dec 31, 2024 | -661.06% |
| Sep 30, 2024 | 1.63% |
| Jun 30, 2024 | 21.62% |
| Mar 31, 2024 | -7.45% |
| Dec 31, 2023 | -31.74% |
| Sep 30, 2023 | 23.55% |
| Jun 30, 2023 | -26.01% |
| Mar 31, 2023 | 30.06% |
| Dec 31, 2022 | 41.21% |
| Sep 30, 2022 | 15.42% |
| Jun 30, 2022 | 7.61% |
| Mar 31, 2022 | 10.97% |
| Dec 31, 2021 | 10.42% |
| Sep 30, 2021 | 6.30% |
| Jun 30, 2021 | 7.31% |
| Mar 31, 2021 | -53.69% |
| Dec 31, 2020 | 6.93% |
| Sep 30, 2020 | -43.33% |
| Jun 30, 2020 | 0.37% |
| Mar 31, 2020 | 4.70% |
| Dec 31, 2019 | -194.00% |
| Sep 30, 2019 | 12.38% |
| Jun 30, 2019 | 12.77% |
| Mar 31, 2019 | 14.68% |
| Dec 31, 2018 | 9.52% |
| Sep 30, 2018 | 7.31% |
| Jun 30, 2018 | 8.41% |
| Mar 31, 2018 | 0.10% |
| Dec 31, 2017 | 15.17% |
| Sep 30, 2017 | -147.30% |
| Jun 30, 2017 | -20.55% |
| Mar 31, 2017 | -23.62% |